Description: From formulation to clinic
The Inhalosome-C project received an Enterprise Award with our partners at the University of Strathclyde: University of Strathclyde Glasgow Enterprise Awards for November 2013 as the Best Academic Commercialisation Project.
An agreement was signed with MacKenzies Partnership Ltd in Harrogate to assist in finding, reviewing, and assessing any potential investors for the project.
The University of Stratchclyde have asked Biovaxpharma Ltd to assist them in developing the commercialisation project for Inhalosome-Cisplatin development for lung cancer via nebulized method of treatment. View more at www.Inhalosome.com